CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 27 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-12 | Glover Stephen C. Director | Grant or award · Employee Stock Option (Right to Buy) | +54,876 | 54,876 | ||
| 2025-06-11 | Glover Stephen C. Director | Grant or award · Employee Stock Option (Right to Buy) | +22,700 | 22,700 | ||
| 2025-02-28 | Glover Stephen C. Director | Purchase | +15,061 | $1.66 | $25K | 78,851 |
| 2025-02-28 | Glover Stephen C. Director | Purchase · Common Warrant | +15,061 | 15,061 | ||
| 2024-06-24 | Glover Stephen C. Director | Grant or award · Employee Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2023-07-14 | Glover Stephen C. Director | Grant or award · Employee Stock Option (Right to Buy) | +9,000 | 9,000 |
Page 1 of 1 · 6 trades